Y-
About
Y-Biologics is specialized in antibody drug since its inception has focused on research and development. They have successfully constructed the unique human antibody library Y-max ABL and new dual antibody platform technology ALiCE. Based on this, they have developed various antibody drugs and become a leading company in the global immuno-chemotherapeutic drug market They are doing their best to leap forward.
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 1,203 investors are based in Seoul, Seoul-t'ukpyolsi, South Korea.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- healthtech biotech
- Location
- Seoul, South Korea
Contact Information
Find more investors like Y-Biologics
Search Investors